by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
SAN RAFAEL, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that two oral and 16 poster presentations related to the company’s products and product candidates will be made at the Society for the Study of...
by GlobeNewsWire | Aug 23, 2016 | Canadian Stocks, Globe Newswire
VANCOUVER, Washington, Aug. 23, 2016 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that the first of 11 HIV-1...
by GlobeNewsWire | Aug 17, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2016 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (Nasdaq:CYTK) today announced the completion of patient enrollment in VITALITY-ALS (Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices after Treatment...
by GlobeNewsWire | Aug 9, 2016 | Globe Newswire
Significant Progress with EU Galafold Launch and Regulatory Submissions Enrollment in Pompe Phase 1/2 Clinical Study on Track with Initial Data Expected in 2H16 Elevation of “Time to Wound Closure” as Co-Primary Endpoint in Ongoing Phase 3 Study of SD-101 for...
by GlobeNewsWire | Jul 28, 2016 | Globe Newswire
MENLO PARK, Calif., July 28, 2016 (GLOBE NEWSWIRE) — Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone (rhGH) for growth hormone...